No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Established in 1952 and headquartered in Liaocheng, China, Dong-E-E-Jiao Co.,Ltd. is a prominent manufacturer and distributor of traditional Chinese remedies, biopharmaceuticals, and wellness food products throughout the Chinese market.
www.dongeejiao.comNo one on the platform currently holds 000423.SZ.
No tracked institution reports a position in 000423.SZ as of their last filing.
No one on the platform has traded 000423.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 32.1% | 21.3% | — | — | — | |
| Rev. Growth % | 12.2% | 14.3% | ||||
| Profit Margin % | 26.2% | 21.5% | 17.9% | |||
| Free Cash Flow Margin % | 34.7% | 46.8% | 24.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $7.3B | +9.6% | $3.03 | $2.95–$3.12 | — | 8 |
| 2027 | $8.1B | +10.6% | $3.38 | $3.16–$3.60 | — | 1 |
| 2028 | $8.9B | +10.2% | $3.74 | $3.50–$3.99 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-21 | $0.65 | $0.62 | -5.4% |
| 2026-04-24 | $0.70 | $0.66 | -5.6% |
| 2026-03-20 | $0.73 | $0.72 | -1.4% |
| 2025-10-24 | $0.70 | $0.71 | +1.7% |
| 2025-08-26 | $0.66 | $0.61 | -7.4% |
| 2025-04-24 | $0.65 | $0.66 | +1.5% |
| 2025-03-20 | $0.62 | $0.63 | +1.6% |
| 2024-10-31 | $0.54 | $0.64 | +18.5% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000423.SZDong-E-E-Jiao Co.,Ltd. | $46.11 | -0.77% | $29.5B | — |
| 000513.SZLivzon Pharmaceutical Group Inc. | $26.58 | -1.56% | $23.6B | — |
| 000623.SZJilin Aodong Pharmaceutical Group Co., Ltd. | $17.40 | -1.02% | $20.8B | — |
| 002262.SZJiangsu Nhwa Pharmaceutical Co., Ltd. | $21.65 | -0.64% | $22.0B | — |
| 002773.SZChengdu Kanghong Pharmaceutical Group Co., Ltd |
| $19.13 |
| -0.16% |
| $17.6B |
| — |
| 600079.SSHumanwell Healthcare (Group) Co.,Ltd. | $18.50 | -0.22% | $30.2B | — |
| 600329.SSTianjin Pharmaceutical Da Ren Tang Group Corporation Limited | $34.08 | -1.59% | $19.4B | — |
Source: Financial Modeling Prep · peers by sector/industry